The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of fadraciclib (CYC065), a novel dual CDK2/9 inhibitor, on patient-derived models of colorectal cancer.
 
Mohammad Zokaasadi
No Relationships to Disclose
 
Erdem Altunel
No Relationships to Disclose
 
Divya Lakshmi Dayanidhi
Employment - Xilis
 
John B Mantyh
No Relationships to Disclose
 
Wylie K Watlington
No Relationships to Disclose
 
Shannon J. McCall
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - SciMed Solutions
 
David Blake
Employment - Cyclacel
 
Jason A. Somarelli
Research Funding - Bristol-Myers Squibb/Celgene; Karyopharm Therapeutics
 
David S. Hsu
Research Funding - Amgen
Patents, Royalties, Other Intellectual Property - Xilis